Pandion Therapeutics Holdco LLC
PAND
NASDAQ
Upcoming IPOs
Expected Listing Date: - -
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
-
Biotechnology & Medical Research
2020-06-26
Public Filing
View Prospectus
Pending
Offering
Price Range: Pending
Shares to be Issued: Pending
Pending
Offering End Date
Offering Price: Pending
Post IPO Outstanding: Pending
Listed
About PAND
Pandion Therapeutics Holdco LLC is a clinical-stage biopharmaceutical company. The Company is focused on developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. It is developing its Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. Its lead product candidate, PT101, a combination of its interleukin-2 (IL-2), mutein effector module with a protein backbone, is designed to selectively expand regulatory Treg cells, without activating proinflammatory cells, such as conventional T cells and natural killer (NK cells).
More

Hot Stocks

Symbol
Price
%Change

Webull offers kinds of Pandion Therapeutics Holdco LLC stock information, including NASDAQ:PAND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAND stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAND stock methods without spending real money on the virtual paper trading platform.